Company / AR per Share
Biogen AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$9.26
FY2025
5-year range
$8.89 / $11.32
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
#7 of 115
Health Care
What the data says
Among 115 Health Care companies, Biogen is in the top 6% for ar per share. AR per Share has fluctuated over the past 10 years, ranging from $6.59 in FY2016 to $11.32 in FY2023.
Based on SEC 10-K filings.
9.26 in FY2025 with a 5-year CAGR of -0.9%. Top quartile in the Health Care sector.
Declined from $11.32 to $9.26 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -6.1%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 115This company $9.26 Sector average $27.09
▼
-65.8% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 5.0% year-over-year.
- Ranks #7 out of 115 companies in the Health Care sector.
- Peak ar per share was recorded in FY2023.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.26 | -5.0% |
| FY2024 | $9.76 | -13.8% |
| FY2023 | $11.32 | +1.2% |
| FY2022 | $11.19 | +25.8% |
| FY2021 | $8.89 | -8.4% |
| FY2020 | $9.70 | +9.2% |
| FY2019 | $8.89 | -2.0% |
| FY2018 | $9.07 | +9.6% |
| FY2017 | $8.28 | +25.5% |
| FY2016 | $6.59 | +26.1% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026